MNCM News

"The two words ‘information’ and ‘communication’ are often used interchangeably, but they signify quite different things. Information is giving out; communication is getting through." -- Sydney J. Harris

Public comment for Colonoscopy Quality Measure Set

MN Community Measurement invites you to provide feedback on a plan to pilot test three Colonoscopy Quality measures that were developed nationally and have had Direct Data Submission (DDS) specifications adapted for data collection and submission. The public comment period will conclude on Monday, December 1st at 11:59 p.m. CST.

Background

Between 2009 and 2011, MN Community Measurement developed a Colonoscopy Quality & Surveillance Measure Set through our multi-stakeholder workgroup process. Five measures were approved for pilot data collection during 2011. They were:

  • Percentage of total volume of colonoscopies that were screening colonoscopies
  • Procedure completion rate for screening colonoscopies
  • Adenoma detection rate for screening colonoscopies
  • Follow-up interval recommendations of 10 years for normal screening colonoscopies
  • Follow-up interval of 3 years for surveillance colonoscopies since most recent colonoscopy

The pilot results showed variation and room for improvement with both follow-up interval measures, as well as the adenoma detection rate measure. However, feedback from medical groups indicated numerous challenges in data collection related to extracting particular data elements and lack of specificity in the data collection guide. As a result, measure development was put on hold; nevertheless, community interest in measuring this area of care remains high.

Since 2011, other similar measures have been developed nationally. Specifically, the American Gastroenterological Association (AGA), American Society for Gastrointestinal Endoscopy (ASGE) and American College of Gastroenterology (ACG), in collaboration with AMA-PCPI, updated the Endoscopy and Polyp Surveillance Measurement Set in 2013 that includes three measures: 1) Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients (NQF#0658, endorsed in 2013); 2) Surveillance Colonoscopy Interval for Patients with a History of Adenomatous Polyps (NQF#0659, endorsed in 2013); and, 3) Comprehensive Colonoscopy Documentation (not endorsed). Additionally, the AGA also recently developed a Screening Colonoscopy Adenoma Detection Rate measure.

Given the progress in measure development in the past three years, MNCM proposes adapting several of the measures above for the DDS process by producing granular file specifications for data collection and submission. In doing so, we can leverage our community’s previous work in this area along with the national efforts by using already-developed and endorsed measures. This is also similar to the process followed to create our Colorectal Cancer Screening measure.

The proposed measures are:

  • Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients (NQF#0658, endorsed in 2013)
  • Surveillance Colonoscopy Interval for Patients with a History of Adenomatous Polyps (NQF#0659, endorsed in 2013)
  • Screening Colonoscopy Adenoma Detection Rate

Public Comment

We are seeking public comment on the plan to pilot test the three measures noted above in 2015 and on the DDS specifications that have been adapted for those measures. This is a set of three individual measures; these are not composite measures.

The DDS specifications can be accessed here: Colonoscopy Quality – DRAFT Direct Data Submission Guide for Public Comment. Feedback should be submitted to publiccomment@mncm.org by Monday, December 1st at 11:59 p.m. CST.

A critical element of developing and testing measures by MNCM is the opportunity for the public to review proposed specifications and recommend changes or clarifications. All comments will be reviewed for consideration. If you have any questions, please contact Jasmine Larson at jlarson@mncm.org or 612-746-4514. We appreciate your time and thoughtful comments.